Public Notices: Peak Powder River Resources, LLC (F031172/A0016113)
Clinical Efficacy Endpoints from the Phase 3 CANOPY Study Evaluating[...]
Pharmacokinetics and Serum Virus Neutralizing Antibody Titers Following[...]
05/20/2024 | Press release | Distributed by Public on 05/20/2024 08:20
Please select the service you want to use:
Smartlinks | Ellaktor SA | Finance | Security Markets | Security Markets | Company News | Investment Funds | Construction and Engineering Companies | Securities Issuers | London Stock Exchange (LSE) | Frankfurt Stock Exchange | Athens Exchange (ATHEX) | Berlin Stock Exchange | Munich Stock Exchange | Stuttgart Stock Exchange | OTC Markets | BX Swiss | Cboe Off Exchange
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact